Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.

Fertility and sterility - 1 Feb 2003

Yoon Byung-Koo, Kim Doh Kwan, Kang Yeonwook, Kim Jong-Won, Shin Myung-Hee, Na Duk L

Abstract excerpt

OBJECTIVE: To compare the therapeutic efficacy of hormone replacement therapy (HRT) and tacrine in Alzheimer's disease. DESIGN: Six-month, randomized, open-label study. SETTING: University hospital. PATIENT(S): Fifty-five women with mild to moderate Alzheimer's disease were randomly assigned to tacrine (n = 26) or HRT (n = 29). INTERVENTION(S): In the tacrine group, an initial dose of 40 mg/day was increased up...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Constitution

Share to Cholinesterase Inhibitors

Share to Estrogen Replacement Therapy

Share to Menarche

Share to Neuropsychological Tests

Share to Postmenopause

Source

Identifiers

PMID: 12568834
DOI: 10.1016/s0015-0282(02)04666-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.PMID 12568834Read ↗

Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.Semantic proximity Read ↗

Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.Semantic proximity Read ↗

Hormone replacement therapy and dementia risk among postmenopausal women: evidence from the UK BiobankSemantic proximity Read ↗

Hormone Replacement Therapy is associated with improved cognition and larger brain volumes in at risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohortSemantic proximity Read ↗

Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.Semantic proximity Read ↗

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.Semantic proximity Read ↗

Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort.Semantic proximity Read ↗

Update on the Neuroprotective Effect of Estrogen Receptor Alpha Against Alzheimer's DiseaseSemantic proximity Read ↗

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.Semantic proximity Read ↗

Hormone replacement therapy--is there a place for its use in neurology?Semantic proximity Read ↗

Women's brain aging: Effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Women’s brain aging: effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.